Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The New US Preventive Services Task Force "C" Draft Recommendation for Prostate Cancer Screening.

Matthew R Cooperberg1

  • 1Departments of Urology and Epidemiology & Biostatistics, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco San Francisco, CA, USA.

European Urology
|May 25, 2017
PubMed
Summary

The US Preventive Services Task Force updated prostate cancer screening guidelines, recommending informed discussion for men 55-69. The evidence review needs improvement for accurate benefit and harm presentation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Comparison of Decipher 1.0 and 1.1 for Localized Prostate Cancer: Results in Prostatectomy and Active Surveillance Patients.

European urology oncology·2025
Same author

Screening for Prostate Cancer with a Polygenic Risk Score.

The New England journal of medicine·2025
Same author

The Role of Liquid Biopsy in the Management of Patients with Genitourinary Malignancies.

European urology·2025
Same author

Controlled trial of decision support for men with early-stage prostate cancer: brief research report of effects on patient knowledge.

Frontiers in urology·2025
Same author

Automated Extraction of Imaging and Pathology Data From Diverse Prostate Cancer Electronic Records.

JCO clinical cancer informatics·2025
Same author

Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer.

European urology focus·2025

Area of Science:

  • Urology
  • Preventive Medicine
  • Public Health Policy

Background:

  • The US Preventive Services Task Force (USPSTF) has released a draft guideline on prostate cancer screening.
  • The draft recommends a "C" grade for men aged 55-69 years, advising shared decision-making regarding prostate-specific antigen (PSA) testing.
  • A "D" grade, or "do not screen" recommendation, remains for men aged 70 years and older.

Related Experiment Videos